175 related articles for article (PubMed ID: 16801082)
1. Can the Platelet Function Analyzer (PFA)-100 test substitute for the template bleeding time in routine clinical practice?
Francis J; Francis D; Larson L; Helms E; Garcia M
Platelets; 1999; 10(2-3):132-6. PubMed ID: 16801082
[TBL] [Abstract][Full Text] [Related]
2. PFA-100 system: a new method for assessment of platelet dysfunction.
Mammen EF; Comp PC; Gosselin R; Greenberg C; Hoots WK; Kessler CM; Larkin EC; Liles D; Nugent DJ
Semin Thromb Hemost; 1998; 24(2):195-202. PubMed ID: 9579642
[TBL] [Abstract][Full Text] [Related]
3. Variables influencing Platelet Function Analyzer-100 closure times in healthy individuals.
Haubelt H; Anders C; Vogt A; Hoerdt P; Seyfert UT; Hellstern P
Br J Haematol; 2005 Sep; 130(5):759-67. PubMed ID: 16115134
[TBL] [Abstract][Full Text] [Related]
4. Perioperative monitoring of primary and secondary hemostasis in coronary artery bypass grafting.
Hertfelder HJ; Bös M; Weber D; Winkler K; Hanfland P; Preusse CJ
Semin Thromb Hemost; 2005; 31(4):426-40. PubMed ID: 16149021
[TBL] [Abstract][Full Text] [Related]
5. Hemodialysis shortens long in vitro closure times as measured by the PFA-100.
Bilgin AU; Karadogan I; Artac M; Kizilors A; Bligin R; Undar L
Med Sci Monit; 2007 Mar; 13(3):CR141-5. PubMed ID: 17325638
[TBL] [Abstract][Full Text] [Related]
6. Platelet function testing to assess effectiveness of platelet transfusion therapy.
Salama ME; Raman S; Drew MJ; Abdel-Raheem M; Mahmood MN
Transfus Apher Sci; 2004 Apr; 30(2):93-100. PubMed ID: 15062745
[TBL] [Abstract][Full Text] [Related]
7. Variables that affect platelet function analyzer-100 (PFA-100) closure times and establishment of reference intervals in Korean adults.
Cho YU; Jang S; Park CJ; Chi HS
Ann Clin Lab Sci; 2008; 38(3):247-53. PubMed ID: 18715853
[TBL] [Abstract][Full Text] [Related]
8. Monitoring aspirin treatment in patients with thrombocytosis: comparison of the platelet function analyzer (PFA)-100 with optical aggregometry.
Tsantes AE; Mantzios G; Giannopoulou V; Tsirigotis P; Bonovas S; Rapti E; Mygiaki E; Kartasis Z; Sitaras NM; Dervenoulas J; Travlou A
Thromb Res; 2008; 123(1):100-7. PubMed ID: 18430462
[TBL] [Abstract][Full Text] [Related]
9. In vitro testing of platelets using the thromboelastogram, platelet function analyzer, and the clot signature analyzer to predict the bleeding time.
Valeri CR; Ragno G
Transfus Apher Sci; 2006 Aug; 35(1):33-41. PubMed ID: 16945586
[TBL] [Abstract][Full Text] [Related]
10. Hypersensitivity of platelets to adenosine diphosphate in patients with stable cardiovascular disease predicts major adverse events despite antiplatelet therapy.
Christie DJ; Kottke-Marchant K; Gorman RT
Platelets; 2008 Mar; 19(2):104-10. PubMed ID: 17852773
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of the INNOVANCE PFA P2Y test cartridge for the detection of patients with congenital defects of the platelet P2Y₁₂ receptor for adenosine diphosphate.
Scavone M; Germanovich K; Femia EA; Cattaneo M
Thromb Res; 2014 Feb; 133(2):254-6. PubMed ID: 24331208
[TBL] [Abstract][Full Text] [Related]
12. Assessment of primary hemostasis by PFA-100 analysis in a tertiary care center.
Ortel TL; James AH; Thames EH; Moore KD; Greenberg CS
Thromb Haemost; 2000 Jul; 84(1):93-7. PubMed ID: 10928477
[TBL] [Abstract][Full Text] [Related]
13. [Clinical evaluation of platelet function analyzer PFA-100 in dogs].
Keidel A; Mischke R
Berl Munch Tierarztl Wochenschr; 1998; 111(11-12):452-6. PubMed ID: 9880941
[TBL] [Abstract][Full Text] [Related]
14. Screening for aspirin resistance in stable coronary artery patients by three different tests.
Chakroun T; Addad F; Abderazek F; Ben-Farhat M; Hamdi S; Gamra H; Hassine M; Ben-Hamda K; Samama MM; Elalamy I
Thromb Res; 2007; 121(3):413-8. PubMed ID: 17553552
[TBL] [Abstract][Full Text] [Related]
15. Investigation of diagnostic importance of platelet closure times measured by Platelet Function Analyzer--PFA 100 in dogs with endotoxemia.
Yilmaz Z; Ilcol YO; Ulus IH
Berl Munch Tierarztl Wochenschr; 2005; 118(7-8):341-8. PubMed ID: 16048047
[TBL] [Abstract][Full Text] [Related]
16. Platelet dysfunction detected at high shear in patients with heart valve disease.
Francis JL
Platelets; 2000 May; 11(3):133-6. PubMed ID: 10938889
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of acquired platelet dysfunctions in uremic and cirrhotic patients using the platelet function analyzer (PFA-100 ): influence of hematocrit elevation.
Escolar G; Cases A; Viñas M; Pino M; Calls J; Cirera I; Ordinas A
Haematologica; 1999 Jul; 84(7):614-9. PubMed ID: 10406903
[TBL] [Abstract][Full Text] [Related]
18. Platelet dysfunction in primary thrombocythemia using the platelet function analyzer, PFA-100.
Cesar JM; de Miguel D; García Avello A; Burgaleta C
Am J Clin Pathol; 2005 May; 123(5):772-7. PubMed ID: 15981818
[TBL] [Abstract][Full Text] [Related]
19. Persistent platelet activation is related to very early cardiovascular events in patients with acute coronary syndromes.
Małek ŁA; Spiewak M; Filipiak KJ; Grabowski M; Szpotańska M; Rosiak M; Główczyńska R; Imiela T; Huczek Z; Opolski G
Kardiol Pol; 2007 Jan; 65(1):40-5; discussion 46. PubMed ID: 17295159
[TBL] [Abstract][Full Text] [Related]
20. Using the Platelet Function Analyzer-100 for monitoring aspirin therapy.
Poulsen TS; Mickley H; Korsholm L; Licht PB; Haghfelt T; Jørgensen B
Thromb Res; 2007; 120(2):161-72. PubMed ID: 17052745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
